Table 2.
Etiology and outcome in patients with acute viral hepatitis (with and without diabetes mellitus).
| Non-diabetic (n = 83) | Diabetic (n = 12) | P value | Total (%) (n = 95) | |
|---|---|---|---|---|
| Etiology | ||||
| IgM anti-HAV | 11 (13.25%) | 1 (8.33%) | 1.0 | 12 (12.63) |
| IgM anti-HBc | 21 (25.30%) | 7 (58.33%) | 0.02 | 28 (30.52) |
| IgM anti-HEV | 51 (61.44%) | 4 (33.33%) | 0.12 | 55 (57.89) |
| Outcome | ||||
| Duration of complete resolution of acute hepatitis (days) | 41.01 ± 22.30 | 41.01 ± 22.30 | 0.741 | – |
| Frequency of severe hepatitis - n.(%) | 9 (10.84%) | 5 (41.67) | 0.005 | – |
| Frequency of Liver Failure-n.(%) | 0 (0) | 2 (16.67) | 0.02 | – |